April 28, 2026

Dietary Fats Linked to Lower Odds of Hearing Loss

NHANES analysis shows inverse dose-response associations for omega-3 and omega-6 intake, with no link for fatty acid ratio

Conexiant

April 28, 2026

Keeping an Eye on Diabetes

Progress, pitfalls and the future of the UK’s Diabetic Eye Screening Program

The Ophthalmologist

April 22, 2026

Tzield Approval Expands to Younger Patients

First disease-modifying option available for children as young as 1 year with stage 2 type 1 diabetes

Conexiant

April 22, 2026

CGM in Early Gestational Diabetes Improved Outcomes

Secondary outcomes favored CGM, including fewer preterm births and neonatal intensive care unit admissions.

Conexiant

April 21, 2026

Two-Drug HIV Regimen Gains FDA Approval

Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes

Conexiant

April 21, 2026

Type 2 Diabetes Linked to SSNHL Risk

Mendelian randomization analysis shows independent association, with no link for type 1 diabetes, obesity, or hyperlipidemia.

Conexiant

April 20, 2026

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

Conexiant

April 20, 2026

BMI-Adjusted Grip Strength and Sarcopenia in Prediabetes

Researchers report 8% prevalence of probable sarcopenia and a 96.4% specificity cutoff for BMI-adjusted grip strength.

Conexiant

April 20, 2026

CT Findings May Signal Bladder Fungal Balls

Case report suggests imaging features could help physicians recognize obstructive fungal masses in high-risk patients

Conexiant

April 17, 2026

Bundled Care Strategy May Reduce Moderate to Severe AKI

Multicenter trial finds KDIGO-recommended approach lowers moderate to severe acute kidney injury; measured 90-day outcomes were similar between groups

Conexiant